Navigation Links
Medbox, Inc. Releases 2nd Quarter Financials
Date:8/20/2012

HOLLYWOOD, Calif., Aug. 20, 2012 /PRNewswire/ -- (Pinksheets: MDBX) (www.medboxinc.com)

Medbox, Inc. released their end of 2nd quarter 2012 financials, which showed earnings of over $820,000 for the three-month period ending June 30. Cash on hand has almost doubled since the beginning of the year, and receivables jumped to an impressive 1.1 million.

Medbox earns all its revenue through consulting services and the sales of their proprietary prescription medicine dispensing systems.

Dr. Bruce Bedrick, CEO of Medbox commented on the company's financial picture. "Our balance sheet remains strong, with key gains brought on by expansion into new markets, particularly in Arizona and Connecticut," he stated. "Medbox is well positioned for future growth and expansion, as we have very little debt, patented technologies, growing market demand for our systems and services, expertise in the industry, and a solid track record."

Recently, the company helped over 75% of its Arizona clients successfully navigate the state's dispensary licensing program. With issuances of over 20 licenses to its consulting clients and being awarded mandatory placements of its technology in those clinics, Medbox has secured itself as the leader in compliant operation as well as a model for overall success in the industry.

In addition, the company is slated to roll out its storage and retrieval system for traditional pharmacies later this year. The system, called the Medbox RX, allows pharmacists to store a consumer's medication for quick and convenient retrieval later by the consumer, via automated biometric kiosk.

"As our company continues to grow, we provide more value for our customers, our employees and our shareholders," Bedrick said. "We look forward to a very rewarding future."

For more information on Medbox, their financials, products or services, please contact the Medbox Investors Relations Department at (800) 762-1452 or go online to www.medboxinc.com.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo, Connecticut, Arizona and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.


'/>"/>
SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
2. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
3. NIST releases Gulf of Mexico crude oil reference material
4. Spanish researcher releases a video showing a beetle from the inside
5. AAO-HNS releases updated Clinical Indicators
6. SF State researcher releases first results from nationwide bee count
7. NSF releases report detailing nationwide and state-by-state R&D activities
8. University of Tennessee professor releases weight management product
9. Aware, Inc. Reports First Quarter 2012 Financial Results
10. One-quarter of grouper species being fished to extinction
11. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)... 2017   Invitae Corporation (NYSE: ... companies, today announced that it will report its fourth ... guidance on Monday, February 13, 2017, and Invitae,s management ... 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... review financial results, guidance, and recent developments and will ...
(Date:1/24/2017)... Biopharm Reports has carried out a ... nuclear magnetic resonance spectroscopy (NMR). This involved the ... practices, developments, trends and end-user plans over the ... opportunities. These areas include growth in the use ... innovation requirements, hyphenated NMR techniques, main suppliers of ...
Breaking Biology News(10 mins):
(Date:2/26/2017)... ... ... Rob Lowe is a well recognized television personality, so it seems natural ... that are important to the American public and important to society at large. An ... topic around the world for a few years. , The climate and how we ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive small business ... had the goal of bringing their powerful cuvette and spectrophotometer calibration to ... that FireflySci is going on as they add yet another mark on the global ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
Breaking Biology Technology: